Keyphrases
Neurofibromatosis Type 1 (NF-1)
100%
Neurofibromatosis Type I
65%
Seizure
30%
Epilepsy
30%
Optic Pathway Glioma
23%
Tuberous Sclerosis Complex
23%
Astrocytes
22%
Magnetic Resonance Imaging
21%
Tumor
20%
Mouse Model
17%
Glioma
17%
Neurofibromin
16%
Neurofibromatosis Type 2
16%
Pediatric
16%
Pediatric multiple Sclerosis
14%
Preterm Infants
14%
Brain Injury
12%
Brain Development
12%
Multiple Sclerosis
12%
Merlin
12%
Functional Magnetic Resonance Imaging
12%
Mammalian Target of Rapamycin (mTOR)
11%
Microglia
11%
Cerebral Palsy
11%
Brain Tumor
11%
Gene Products
10%
Functional Connectivity
10%
Very Preterm Infants
10%
Meningioma
10%
Knock-in Mouse Model
9%
Neurofibromatosis
9%
Pilocytic Astrocytoma
9%
Resting-state Functional Magnetic Resonance Imaging (rs-fMRI)
9%
Clubfoot
9%
Apparent Diffusion Coefficient
9%
Dystonia
9%
Sickle Cell Disease
9%
Low-grade Glioma
9%
Confidence Interval
9%
Neonate
8%
Tumor Suppressor
8%
Epileptogenesis
8%
Malignant Peripheral Nerve Sheath Tumor (MPNST)
8%
Clinical Trials
7%
Central Nervous System
7%
Resting-state Functional Connectivity (rs-FC)
7%
Electroencephalography
7%
Tumor Suppressor Gene
7%
Adolescent Idiopathic Scoliosis
7%
Neuroimaging
6%
Clinical Features
6%
TSC1
6%
Brain Regions
6%
Cell Growth
6%
Cortex
6%
Astrocytoma
6%
Human Brain
6%
Silent Cerebral Infarction
6%
Diffusion Tensor Imaging
6%
COVID-19
6%
Neurodevelopmental Disorders
6%
Odds Ratio
6%
Pediatric Patients
6%
Diffusion Magnetic Resonance Imaging (dMRI)
5%
Glioma Growth
5%
Neurodevelopmental Outcome
5%
Movement Disorders
5%
Developmental Delay
5%
Cerebrospinal Fluid
5%
Nervous System
5%
White Matter
5%
Etiology
5%
Functional Networks
5%
Cell Proliferation
5%
Rapamycin
5%
Mammalian Target of Rapamycin Pathway
5%
Cultured Hippocampal Neurons
5%
Overexpression
5%
Neonatal Intensive Care Unit
5%
Intellectual Disability
5%
Sickle Cell Anemia
5%
Term-equivalent Age
5%
NF-2
5%
Neuroscience
Neurofibromatosis Type 1
54%
Magnetic Resonance Imaging
26%
Magnetic Resonance Imaging
25%
Astrocyte
25%
Tuberous Sclerosis
20%
Functional Magnetic Resonance Imaging
19%
In Vivo
18%
Functional Connectivity
16%
Behavior (Neuroscience)
13%
Merlin
12%
Dystonia
12%
Microglia
12%
Mammalian Target of Rapamycin
11%
Brain Development
11%
Neurofibromatosis Type II
11%
Multiple Sclerosis
10%
Cerebral Palsy
10%
Intracranial Tumor
10%
In Vitro
10%
Central Nervous System
9%
Resting-State Functional Connectivity
9%
Stereotypic Movement Disorder
9%
Astrocytoma
9%
Gene Product
8%
Gene Expression
8%
Tumor Suppressor Gene
8%
Meningioma
8%
Receptor
7%
Cerebrovascular Accident
7%
Epileptogenesis
7%
Hydrocephalus
7%
Brain Network
7%
Tumor Suppressor Protein
7%
Diffusion MRI
7%
Pilocytic Astrocytoma
7%
Brain Ischemia
7%
Optic Nerve
6%
Cell Growth
6%
Hippocampus
6%
Cognitive Disorders
6%
Focal Epilepsy
6%
Cyclic Adenosine Monophosphate
6%
Gamma-Aminobutyric Acid
6%
Brain Disease
6%
Gray Matter
6%
Attention Deficit Hyperactivity Disorder
6%
Electroencephalogram
6%
Gene Mutation
5%
Low-Grade Glioma
5%
Autism
5%
Glutamic Acid
5%
Diffusion Tensor Imaging
5%
Cell Proliferation
5%
Brain Function
5%
Status Epilepticus
5%
Sirolimus
5%
Medicine and Dentistry
Neurofibromatosis Type I
67%
Pediatrics
42%
Ganglioglioma
33%
Neoplasm
28%
Epileptic Seizure
24%
Magnetic Resonance Imaging
24%
Diseases
20%
Multiple Sclerosis
12%
Intracranial Tumor
11%
Prematurity
10%
Sickle-Cell Disease
10%
Brain Injury
10%
Neurofibromatosis
9%
Apoplexy
9%
Optic Nerve Glioma
9%
Spastic Diplegia
8%
Malignant Neoplasm
8%
Clinical Trial
7%
Disease
7%
Diagnosis
7%
Neurofibromatosis Type II
7%
Plexiform Neurofibroma
7%
Microglia
7%
Tuberous Sclerosis
7%
Carcinogenesis
7%
Clubfoot
7%
Mechanistic Target of Rapamycin
7%
Cancer
6%
Brain Disease
6%
Neonate
6%
Cerebrospinal Fluid
6%
Developmental Delay
5%
Malignant Peripheral Nerve Sheath Tumor
5%
Pilocytic Astrocytoma
5%
Prevalence
5%
Neonatal Infant
5%
Dystonia
5%
Odds Ratio
5%
Brain Ischemia
5%
Pediatrics Patient
5%
Central Nervous System
5%
Adolescence
5%